- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06061939
Effects of Blood Flow Restriction Training on Middle-aged People With Multiple Sclerosis.
Effects of a Resistance Training Program Based on Blood Flow Restriction Training for People Over 45 Years of Age With Multiple Sclerosis on Muscle Strength and Functionality.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This research corresponds to an experimental study, a double-blind randomized controlled clinical trial, where a total of blood flow (n = X) 12 weeks; and the control group (n= X) that will only receive general recommendations about the benefits of physical exercise. The variables will be measured for both groups with the same validated tools and the same researcher to avoid information bias and differential misclassification. The evaluations will be carried out at the beginning of the intervention and immediately after the end of this period, and the results will be noted in a data record that will later be unified in an Excel database, registering a code for each participant to maintain condition. of privacy, but at the same time allow the required comparability.
For the independent variables, sociodemographic characteristics, clinical history and the socio-familial assessment scale will be addressed; For their part, the result variables are divided by areas: those focused on the health status of patients with MS will measure the level of disability through the Expanded Disability Status Scale (EDSS), the impact of MS through the Multiple Sclerosis Impact Scale 29 (MSIS-29) and health-related quality of life (HRQoL) with the Short Form-36 (SF-36). For the physical condition variables, the Maximal Voluntary Isometric Contraction (MVIC) will be used with a dynamometer to measure general muscle strength and grip strength, as well as the Sit to Stand-5 repetitions (STS-5) and the Sit to Stand-5 repetitions (STS-5). 30 seconds (STS-30) to evaluate lower limb strength. For the functional variables, the impact on walking is evaluated using the Timed 25-Foot Walking Test (T25FWT); gait speed with the 10-Meters Walk Test (10-MWT) and Timed Up and Go (TUG); while walking endurance will be measured with the 6-Minute Walk Test (6-MWT). For its part, postural stability and balance from the Berg Balance Scale (BBS). To evaluate the level of physical activity, Godin Leisure-Time Exercise Questionnaire scores (GLTEQ) will be used. The questionnaire to determine fatigue will be the Fatigue Severity Scale (FSS) and the one in charge of measuring cognitive function will be the Symbol Digit Modalities Test (SDMT). On the other hand, in the psychological variables, the Hospital Anxiety and Depression Scale (HADS) will be applied for anxiety and depression and the Perceived Stress Scale (PSS) for the stress level. Finally, to measure sleep quality, the Pittsburgh Sleep Quality Index (PSQI) will be used. All variables will have pre and post intervention measurements. As a result, a training program with blood flow restriction is expected to improve the health status, muscle strength, functionality and psychological domains of middle-aged patients (> 45 years) with MS, thus contributing to the comprehensive approach of this population. Once the intervention is completed, the final evaluation will be carried out and, based on the comparative process, define whether there are significant differences with respect to the results initially obtained.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Jaén, Spain, 23440
- Asociación Jiennense de Esclerosis Múltiple
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male and female users over 45 years of age, who voluntarily agree to participate in the study, who are able to understand the instructions and exercise protocols of this project.
Exclusion Criteria:
- People with contraindications for performing physical tests or exercise. Users with a diagnosis of pathologies such as cancer, pulmonary hypertension and kidney failure, population with a diagnosis of heart disease or heart failure, population with a diagnosis and/or under psychiatric management, with neurological or cognitive alterations will be excluded. Population diagnosed with Human Immunodeficiency Virus infection or disease (HIV/AIDS). Population that does not agree to participate in the study or who, at the time of entering the program, have denied the endorsement of the use of their data for research in the informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
A control group (CG) that will not undergo treatment, which will be evaluated in the pre and post phase of the study.
Participants assigned to this group will receive general advice on the positive effects of regular physical activity, and they will be given the guide of recommendations for the promotion of physical activity.
|
|
|
Experimental: Intervention Group
An experimental group (EG) that after an initial evaluation and with their consent, will be subjected to a directed physical training program, based on strength training with blood flow restriction, applied for 12 weeks with 3 weekly sessions (Monday, Wednesday and Friday), with a duration of 30-45 minutes per session.
The exercises to be performed will be divided into three different phases: warm-up during the first 10 minutes; the main part with a duration of 15 minutes (where each exercise must be performed doing 4 series with a pattern of 30-15-15-15 repetitions, resting 30-45 seconds between series and 1-2 minutes between exercises); and the return to calm, based above all on stretching exercises with a total duration of 10 minutes.
|
A strength training program with blood flow restriction will be performed for 12 weeks, with 30-45 minute sessions on Mondays, Wednesdays and Fridays.
Each session includes a warm-up, the main part with specific exercises and a cool-down with stretching.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disability Status
Time Frame: Up to twelve weeks
|
Expanded Disability Status Scale (EDSS).
Method to quantify disability in multiple sclerosis and monitor changes in the level of disability over time.
It is widely used in clinical trials and in the evaluation of people with MS.
The EDSS scale ranges from 0 to 10 units with 0.5 point increments representing higher levels of disability.
The first levels 1.0 to 4.5 refer to people with a high degree of ambulatory capacity and the later levels 5.0 to 9.5 refer to the loss of ambulatory capacity.
|
Up to twelve weeks
|
|
Multiple Sclerosis Impact
Time Frame: Up to twelve weeks
|
Multiple Sclerosis Impact Scale 29 (MSIS-29).
It is a 29-item, condition-specific self-report questionnaire to measure the impact of MS on people's lives.
It has two subscales: a 20-item physical impact scale and a 9-item psychological impact scale.
It is currently in its second version, which has four-point response categories for each item: "not at all," "a little," "moderately," and "extremely."
The physical impact scale can range from 20 to 80 and the psychological impact scale from 9 to 36, with lower scores indicating little impact of MS and higher scores indicating greater impact.
|
Up to twelve weeks
|
|
Short Form-36 (SF-36).
Time Frame: Up to twelve weeks
|
It is the most used scale for the general evaluation of health-related quality of life and consists of 36 items that are grouped into eight subscales or domains: (i) physical functioning (ten items); (ii) physical role (four items); (iii) body pain (two items); (iv) general health (five articles); (v) vitality (four items); (vi) social functioning (two items); (vii) emotional role (three items); and (viii) mental health (five items).
The SF-36 also provides summary assessment for the physical and mental components (PCS and MCS, respectively).
Higher scores reveal better overall HRQoL.
|
Up to twelve weeks
|
|
Muscle strength
Time Frame: Up to twelve weeks
|
Maximal Voluntary Isometric Contraction (MVIC) with the use of a dynamometer, a standardized method to measure muscle strength in patients with neuromuscular diseases5.
Sit to Stand-5 repetitions (STS-5) along with Sit to Stand-30 seconds (STS-30) for MMII strength.
In these tests, the patient must get up from a chair and measure the time it takes to perform 5 repetitions or quantify the number of repetitions that the patient is able to perform in 30 seconds6,7.
For STS-5 the cut-off point is set at 9.4 sec.
for those under 60 years of age; 11.4 sec.
between 60 to 69 years old; 12.6 sec.
70 to 79 years and 14.9 sec.
between 80 to 89 years, below these values there would be muscle dysfunction8.
In the STS-30, scores lower than 8 repetitions imply muscle dysfunction.
|
Up to twelve weeks
|
|
Gait impact
Time Frame: Up to twelve weeks
|
Timed 25-Foot Walking Test (T25FWT).
It consists of measuring the time required to travel a distance of 25 feet (7.5 meters).
A time below 6 seconds means a functional gait, between 6 and 7.99 seconds means moderate gait dysfunction and 8 seconds or more means gait dysfunction.
|
Up to twelve weeks
|
|
Anxiety and depression
Time Frame: Up to twelve weeks
|
Hospital Anxiety and Depression Scale (HADS).
This scale consists of 14 items with 4 response alternatives ranging from 0 to 3 for a total of 0 to 21 points.
It has 2 subscales and the score is obtained by adding the scores of each item that make it up, the interpretation criteria being the following: Range of normality (0-7), Possible case of anxiety or depression (8-10) and Case of anxiety or depression (11-21).
|
Up to twelve weeks
|
|
Sleep quality
Time Frame: Up to twelve weeks
|
Pittsburgh Sleep Quality Index (PSQI).
The PSQI consists of 19 self-assessment questions or items and 5 more to be completed by the person with whom the participant shares a bed or room (although the latter is only used to provide clinical information).
These items generate a total score and 7 components or domains: sleep quality; sleep latency; sleep duration; sleep efficiency; sleep disorders; use of sleeping medications; daytime dysfunction.
The PSQI total score ranges from 0 to 21, with a higher score indicating poorer sleep quality.
|
Up to twelve weeks
|
|
Walking speed
Time Frame: Up to twelve weeks
|
10-Meters Walk Test (10-MWT) and Timed Up and Go (TUG).
10-MWT is used to measure walking speed and consists of measuring the time taken to travel 10 meters of distance11.
The cut-off point is set by the walking speed in m/s, so there is no gait limitation if the speed is <0.40 m/s; moderate limitation if 0.40 to <0.80 m/s; and gait limitation ≥0.80 m/s12.
On the other hand, the TUG consists of measuring the time it takes for the person to get up from a chair, walk 3 meters at their usual pace, turn around, return to the chair and sit down. 2 attempts are made and the best time is chosen.
It is considered low risk of falling if the time is < 10 seconds, slight risk of falling if the time is between 10-20 seconds, and high risk of falling if the time is > 20 seconds.
|
Up to twelve weeks
|
|
Physical fitness
Time Frame: Up to twelve weeks
|
Godin Leisure-Time Exercise Questionnaire (GLTEQ).
This questionnaire consists of 3 items divided according to the intensity of the exercises performed.
For each item, a score is added based on the participant's response.
The scores of the items will be added, considering that the physical activity carried out is Intense ≥ 24 units, Moderate ≥14 and ≤23 units and Light < 14 units.
|
Up to twelve weeks
|
|
Walking endurance
Time Frame: Up to twelve weeks
|
6-Minute Walk Test (6-MWT).
Test commonly used for the objective evaluation of functional exercise capacity.
The patient is asked to walk (minimum in a 30 meter hallway) for a period of 6 minutes, with the primary outcome measure being the distance walked in 6 minutes measured in meters.
In general, normal ranges are between 400-700 meters, with a value below 400 meters being an indicator of low aerobic capacity and good above 700 meters.
|
Up to twelve weeks
|
|
Fatigue
Time Frame: Up to twelve weeks
|
Fatigue Severity Scale (FSS).
One of the most widely used self-report tools to assess fatigue.
It is made up of nine elements (1 to 7).
The average score of the nine items is used as the total score of the FSS.
A higher score indicates greater severity of fatigue.
MID ranges from 0.5 to 1.2 for FSS total score.
|
Up to twelve weeks
|
|
Balance and gait
Time Frame: Up to twelve weeks
|
Tinetti.
Completion time: 8-10 minutes.
While walking behind the patient, the evaluator asks them to respond to the questions from the gait subscale.
To answer the balance subscale, the interviewer stands next to the patient.
A higher score indicates better functioning.
The maximum score for the gait subscale is 12, and for the balance subscale, it is 16.
The sum of both scores is used to assess the risk of falls.
A higher score indicates a lower risk.
A score of less than 19 signifies a high risk of falls.
|
Up to twelve weeks
|
|
Multiple Sclerosis Quality of Life-54
Time Frame: Up to twelve weeks
|
There is no single overall score for the MSQOL-54.
Two summary scores - physical health and mental health - can be derived from a weighted combination of scale scores.
In addition, there are 12 subscales: physical function, role limitations-physical, role limitations-emotional, pain, emotional well-being, energy, health perceptions, social function, cognitive function, health distress, overall quality of life, and sexual function.
There are also two single-item measures: satisfaction with sexual function and change in health.
|
Up to twelve weeks
|
|
Executive functions
Time Frame: Up to twelve weeks
|
The Trail Making Test (TMT) will be used for the assessment of executive function and specifically measures timed visual and motor tasks.
This test is divided into two parts: part A (TMT-A) is responsible for evaluating psychomotor attention and speed and consists of connecting consecutively numbered circles; and Part B (TMT-B), which is based on connecting alternating circles of letters and numbers and measures executive function.
A longer time spent completing the test is interpreted as worse performance.
|
Up to twelve weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mini-Mental State Examination (MMSE)
Time Frame: Up to twelve weeks
|
The most widely used cognitive screening test to assess suspected symptoms consistent with cognitive impairment or dementia.
Written test with a maximum score of 30.
The cut-off point established for the MMSE defines "normal" cognitive function is generally set at 24, lower scores indicate more serious cognitive problems.
|
Up to twelve weeks
|
|
MoCA (Montreal Cognitive Assessment)
Time Frame: Up to twelve weeks
|
Instrument that examines the skills of attention, concentration, executive functions, memory, language, visuoconstructive abilities, calculation and orientation and the maximum score is 30.
|
Up to twelve weeks
|
|
Chair sit and reach test
Time Frame: Up to twelve weeks
|
To test low back and hamstring flexibility.
|
Up to twelve weeks
|
|
Back scratch test
Time Frame: Up to twelve weeks
|
To measure general shoulder range of motion.
|
Up to twelve weeks
|
|
Stress level
Time Frame: Up to twelve weeks
|
Perceived Stress Scale (PSS).
This scale is a self-report instrument that evaluates the level of perceived stress during the last month, it consists of 14 items with a response format of a five-point scale (0 = never, 1 = almost never, 2 = occasionally when, 3 = often, 4 = very often).
The total score of the PSS is obtained by reversing the scores of items 4, 5, 6, 7, 9, 10 and 13 (in the following sense: 0=4, 1=3, 2=2, 3=1 and 4 =0) and then adding the 14 items.
The direct score obtained indicates that a higher score corresponds to a higher level of perceived stress.
|
Up to twelve weeks
|
|
Symbol Digit Modalities Test (SDMT)
Time Frame: Up to twelve weeks
|
This test measures processing speed.
The SDMT sheet consists of a header with a key that relates the numbers 1 to 9 with different symbols.
Below is a template with several symbols that must be assigned the corresponding number.
The patient completes the first ten boxes to familiarize himself and then has 90 seconds to complete the greatest number of boxes.
44 is considered the cut-off point, so scores below 44 imply abnormal cognitive functioning, with 44 points onwards being normal.
|
Up to twelve weeks
|
|
Isaacs Test.
Time Frame: Up to twelve weeks
|
This test measures verbal fluency.
The patient is asked to name as many elements as she can remember from each of the 4 categories: colors, animals, fruits and cities.
One point is awarded for each correct item, with a maximum of 10 scoring items in each set.
The patient has a maximum of 1 minute per category.
Repetitions or names that do not belong to the requested category do not score, although it is useful to note the number of such cases.
Always write down the names that the patient mentions, as this will help in evaluating the patient's progress.
The score ranges between 0 and 40 points.
The cut-off point for detecting dementia, in the Spanish validation, is equal to or less than 29 in adults, and equal to or less than 27 in older people.
Furthermore, a cut-off point of 25 is proposed to consider probable Alzheimer's dementia, with a sensitivity of 87% and a specificity of 67%, resulting in a misclassification rate of 24%.
|
Up to twelve weeks
|
|
Stoicism
Time Frame: Up to twelve weeks
|
Liverpool Stoicism Scale.
The LSS is a self-reported questionnaire designed to measure stoicism; it consists of 20 items whose content refers to lack of emotional involvement, dislike for openly expressing emotion, and the ability to withstand emotion.
Responses were recorded on a 5-point Likert scale ranging from strongly disagree to strongly agree.
To prevent response bias, half of the questions were posed in such a way that agreement was synonymous with high stoicism, whereas for the other half, disagreement indicated a high level of stoicism.
The answers to these questions were evaluated in reverse.
Ten items (1, 2, 5, 7, 9, 12, 13, 15, 17, and 18) are reverse-scored.
The minimum sum score is 20 and the maximum is 100.
Higher scores indicate greater stoicism levels.
The original version is reported to have acceptable internal consistency.
|
Up to twelve weeks
|
|
Hand coordination
Time Frame: Up to twelve weeks
|
9 Hole Peg Test.
The Nine Hole Peg Test is a simple and quick assessment tool that we occupational therapists use to evaluate manipulative dexterity, eye-hand coordination, and other upper limb functions in people with neurological impairments.
It involves placing and removing nine pegs in the shortest possible time.
The shorter the time, the better the score.
|
Up to twelve weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- University of Jaén*
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sclerosis, Multiple
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; University of Copenhagen and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
Clinical Trials on Blood Flow Restriction training with Oclussion Cuff.
-
University of MinnesotaFairview Health ServicesCompleted
-
University of Colorado, DenverRecruitingACL TearUnited States
-
Riphah International UniversityNot yet recruiting
-
Mayo ClinicCompleted
-
Paulista UniversityCoordination for the Improvement of Higher Education PersonnelEnrolling by invitationHypertrophy | Muscle StrengthBrazil
-
Paulista UniversityEnrolling by invitationHypertrophy | Muscle StrengthBrazil
-
University GhentFund for Scientific Research, Flanders, BelgiumCompleted
-
Paulista UniversityEnrolling by invitationHypertrophy | Muscle StrengthBrazil
-
The Methodist Hospital Research InstituteActive, not recruitingDistal Radius FracturesUnited States
-
Sahmyook UniversityCompletedDepression | Cognition | Muscle Strength | Resistance Training | Balance | Elderly (People Aged 65 or More) | Blood Flow Restriction ExerciseKorea, Republic of